North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.140

-16.2%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (302)	2/14/1998 9:07:00 AM
From: andy harrison	Read Replies (1) of 507

Doc: I dont think that this is NVX as the date of testing says 1992-1995 and I dont believe NVX was up and running yet on their Menigitis. They received their patents protecting their polysaccaride method only last year (I believe). Don probably has the data and can post. NVX is working on a Menigitis Vaccine with an institution in England of which Don can most likely give more detailed info. NVX is also working on another vaccine with Connaught as was previously posted On a separate note.Abbott Labs just announced a 2 for 1 stock split and increased the quarterly dividend 11% to 30 cents per quarter.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next